2581 |
6OAO |
H_G |
092096 scFv |
Duffy binding surface protein region II |
Plasmodium vivax, Homo sapiens |
XRD |
3.5 | 10.1038/s41564-019-0461-2 |
2582 |
6OAO |
J_I |
092096 scFv |
Duffy binding surface protein region II |
Plasmodium vivax, Homo sapiens |
XRD |
3.5 | 10.1038/s41564-019-0461-2 |
2583 |
6OAO |
L_K |
092096 scFv |
Duffy binding surface protein region II |
Plasmodium vivax, Homo sapiens |
XRD |
3.5 | 10.1038/s41564-019-0461-2 |
2584 |
6OC3 |
AB_F |
FluA-20 Fab |
Influenza A virus H1N1 hemagglutinin |
Homo sapiens, Influenza A virus (A/Solomon Islands/3/2006(H1N1)) |
XRD |
2.85 | 10.1016/j.cell.2019.04.011 |
2585 |
6OC3 |
CD_E |
FluA-20 Fab |
Influenza A virus H1N1 hemagglutinin |
Homo sapiens, Influenza A virus (A/Solomon Islands/3/2006(H1N1)) |
XRD |
2.85 | 10.1016/j.cell.2019.04.011 |
2586 |
6OCB |
HL_A |
FluA-20 Fab |
Influenza A virus H3N2 hemagglutinin |
Homo sapiens, Influenza A virus (A/Hong Kong/1/1968(H3N2)) |
XRD |
2.1 | 10.1016/j.cell.2019.04.011 |
2587 |
6OE4 |
BC_A |
CR9501 Fab |
espiratory syncytial virus (RSV) F Fusion glycoprotein F0 |
Human respiratory syncytial virus A2, Homo sapiens |
XRD |
3.3 | 10.1038/s41467-019-09807-5 |
2588 |
6OE4 |
EF_D |
CR9501 Fab |
espiratory syncytial virus (RSV) F Fusion glycoprotein F0 |
Human respiratory syncytial virus A2, Homo sapiens |
XRD |
3.3 | 10.1038/s41467-019-09807-5 |
2589 |
6OE5 |
BC_A |
Motavizumab Fab |
espiratory syncytial virus (RSV) F Fusion glycoprotein F0 |
Human respiratory syncytial virus A2, Tequatrovirus T4, Mus musculus, Homo sapiens |
XRD |
4.1 | 10.1038/s41467-019-09807-5 |
2590 |
6OE5 |
HL_A |
CR9501 Fab |
espiratory syncytial virus (RSV) F Fusion glycoprotein F0 |
Human respiratory syncytial virus A2, Tequatrovirus T4, Mus musculus, Homo sapiens |
XRD |
4.1 | 10.1038/s41467-019-09807-5 |
2591 |
6OEJ |
HL_G |
C11 Fab |
HIV-1 clade A/E strain 93TH057 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
XRD |
3.45 | 10.1128/mBio.00208-20 |
2592 |
6OEJ |
BC_A |
C11 Fab |
HIV-1 clade A/E strain 93TH057 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
XRD |
3.45 | 10.1128/mBio.00208-20 |
2593 |
6OFI |
HL_G |
CH55 Fab |
HIV-1 clade A/E strain 93TH057 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
XRD |
3.85 | 10.1128/mBio.00208-20 |
2594 |
6OGE |
CB_A |
Pertuzumab Fab |
Receptor tyrosine-protein kinase erbB-2 |
Homo sapiens |
EM |
4.36 | 10.1371/journal.pone.0216095 |
2595 |
6OGE |
ED_A |
Trastuzumab Fab |
Receptor tyrosine-protein kinase erbB-2 |
Homo sapiens |
EM |
4.36 | 10.1371/journal.pone.0216095 |
2596 |
6OGX |
CD_G |
6OGX_1 Fab |
Tumor necrosis factor receptor superfamily member 4 (CD134) |
Homo sapiens |
XRD |
2.77 | 10.1080/19420862.2019.1625662 |
2597 |
6OGX |
HL_G |
6OGX_2 Fab |
Tumor necrosis factor receptor superfamily member 4 (CD134) |
Homo sapiens |
XRD |
2.77 | 10.1080/19420862.2019.1625662 |
2598 |
6OHG |
CB_A |
4F12 Fab |
Plasmodium falciparum vaccine candidateGametocyte surface protein P230 |
Plasmodium falciparum, Mus musculus |
XRD |
2.38 | 10.1038/s42003-020-01123-9 |
2599 |
6OKP |
KL_E |
10-1074 Fab |
HIV-1 B41 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.28 | 10.1016/j.immuni.2019.04.014 |
2600 |
6OKP |
MN_D |
SF12 Fab |
HIV-1 B41 SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.28 | 10.1016/j.immuni.2019.04.014 |